Published in J Infect on October 24, 2012
Clostridium difficile infection: epidemiology, diagnosis and understanding transmission. Nat Rev Gastroenterol Hepatol (2016) 1.03
In vivo assessment of SMT19969 in a hamster model of clostridium difficile infection. Antimicrob Agents Chemother (2014) 0.89
Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection. J Antimicrob Chemother (2015) 0.88
Challenges for standardization of Clostridium difficile typing methods. J Clin Microbiol (2013) 0.88
Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection. J Antimicrob Chemother (2014) 0.86
A low complexity rapid molecular method for detection of Clostridium difficile in stool. PLoS One (2014) 0.84
Use of mCherry Red fluorescent protein for studies of protein localization and gene expression in Clostridium difficile. Appl Environ Microbiol (2014) 0.84
Clostridium difficile infection in older adults. Aging health (2013) 0.81
Factors influencing the development of antibiotic associated diarrhea in ED patients discharged home: risk of administering IV antibiotics. Am J Emerg Med (2014) 0.80
Differential stress transcriptome landscape of historic and recently emerged hypervirulent strains of Clostridium difficile strains determined using RNA-seq. PLoS One (2013) 0.80
The First Two Clostridium difficile Ribotype 027/ST1 Isolates Identified in Beijing, China-an Emerging Problem or a Neglected Threat? Sci Rep (2016) 0.80
Recurrent Clostridium difficile infections: the importance of the intestinal microbiota. World J Gastroenterol (2014) 0.79
Impact of Variations in Test Method Parameters on In Vitro Activity of Surotomycin against Clostridium difficile and Surotomycin Quality Control Limits for Broth Microdilution and Agar Dilution Susceptibility Testing. J Clin Microbiol (2015) 0.78
The first case of severe Clostridium difficile ribotype 027 infection in Taiwan. J Infect (2014) 0.76
Epidemiology and Recurrence Rates of Clostridium difficile Infections in Germany: A Secondary Data Analysis. Infect Dis Ther (2016) 0.75
Treatment of bacterial skin infections in ED observation units: factors influencing prescribing practice. Am J Emerg Med (2015) 0.75
Longitudinal survey of Clostridium difficile presence and gut microbiota composition in a Belgian nursing home. BMC Microbiol (2016) 0.75
Clostridium difficile: A healthcare-associated infection of unknown significance in adults in sub-Saharan Africa. Malawi Med J (2016) 0.75
Surveillance of Clostridium difficile Infections: Results from a Six-Year Retrospective Study in Nine Hospitals of a North Italian Local Health Authority. Int J Environ Res Public Health (2017) 0.75
Can we improve the therapy of Clostridium difficile infection in elderly patients? Wien Klin Wochenschr (2016) 0.75
Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med (2009) 8.30
Once versus thrice daily gentamicin in patients with serious infections. Lancet (1993) 4.92
The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev (2010) 4.48
European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect (2014) 3.33
epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect (2007) 2.77
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect (2009) 2.69
[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin]. Ned Tijdschr Geneeskd (2004) 2.55
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect (2009) 2.44
Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups. Lancet (1989) 2.39
Application of whole-cell DNA restriction endonuclease profiles to the epidemiology of Clostridium difficile-induced diarrhea. J Clin Microbiol (1987) 2.34
Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. J Hosp Infect (2012) 2.31
Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J Med Microbiol (2008) 2.17
Hospital disinfectants and spore formation by Clostridium difficile. Lancet (2000) 2.13
Characteristics of successive epidemics of respiratory syncytial virus infection. Lancet (1991) 2.02
Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect (2008) 2.01
Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis (2007) 1.97
Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removal. Lancet (1999) 1.96
Fusobacterium nucleatum septicemia and portal vein thrombosis. Clin Infect Dis (1999) 1.83
Prevalence of Campylobacter-associated diarrhea among patients infected with human immunodeficiency virus. Clin Infect Dis (1997) 1.80
Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005. Clin Microbiol Infect (2007) 1.66
The slime of coagulase-negative staphylococci: biochemistry and relation to adherence. FEMS Microbiol Rev (1993) 1.62
Prospective evaluation of hospital isolation room capacity. J Hosp Infect (2006) 1.59
Evaluation of chromogenic meticillin-resistant Staphylococcus aureus media: sensitivity versus turnaround time. J Hosp Infect (2012) 1.58
Real-time PCR assay using fine-needle aspirates and tissue biopsy specimens for rapid diagnosis of mycobacterial lymphadenitis in children. J Clin Microbiol (2004) 1.57
Methicillin-resistant Staphylococcus aureus in trauma and orthopaedic practice. J Bone Joint Surg Br (2005) 1.54
Inherited complement deficiency in children surviving fulminant meningococcal septic shock. Eur J Pediatr (1995) 1.53
Clostridium difficile infection in the community: a zoonotic disease? Clin Microbiol Infect (2012) 1.52
Comparison of two matrix-assisted laser desorption ionisation-time of flight mass spectrometry methods for the identification of clinically relevant anaerobic bacteria. Clin Microbiol Infect (2011) 1.51
Aeromonas infections and their treatment. J Antimicrob Chemother (1995) 1.49
Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother (1994) 1.48
Potential for aerosolization of Clostridium difficile after flushing toilets: the role of toilet lids in reducing environmental contamination risk. J Hosp Infect (2011) 1.47
The effects of storage conditions on viability of Clostridium difficile vegetative cells and spores and toxin activity in human faeces. J Clin Pathol (2003) 1.46
Lignocaine spray applicators are a potential source of cross-infection in the anaesthetic room. Anaesthesia (1993) 1.44
Ciprofloxacin and CAPD peritonitis. J Antimicrob Chemother (1990) 1.40
[Diarrhea due to Clostridium difficile toxin in hemato-oncological patients]. Ned Tijdschr Geneeskd (2001) 1.39
Does hospital cleanliness correlate with methicillin-resistant Staphylococcus aureus bacteraemia rates? J Hosp Infect (2006) 1.39
Slime production and adherence by coagulase-negative staphylococci. J Hosp Infect (1991) 1.39
Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. J Hosp Infect (2004) 1.37
Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes. Immunology (1994) 1.35
Rapid diagnosis of toxinogenic Clostridium difficile in faecal samples with internally controlled real-time PCR. Clin Microbiol Infect (2006) 1.34
Application of multiple-locus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficile in a general hospital in Buenos Aires, Argentina. Clin Microbiol Infect (2009) 1.34
Reduced susceptibility of Clostridium difficile to metronidazole. J Antimicrob Chemother (2001) 1.32
Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol (2006) 1.31
Assessment of complement deficiency in patients with meningococcal disease in The Netherlands. Clin Infect Dis (1999) 1.30
Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum. Infect Immun (1995) 1.30
Use of highly discriminatory fingerprinting to analyze clusters of Clostridium difficile infection cases due to epidemic ribotype 027 strains. J Clin Microbiol (2008) 1.30
The susceptibility of Mycobacterium tuberculosis to isoniazid and the Arg-->Leu mutation at codon 463 of katG are not associated. J Clin Microbiol (2001) 1.27
Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands. Clin Microbiol Infect (2009) 1.27
Evaluation of a novel endoluminal brush method for in situ diagnosis of catheter related sepsis. J Clin Pathol (1997) 1.26
Characterization of cell envelope proteins of Staphylococcus epidermidis cultured in human peritoneal dialysate. Infect Immun (1991) 1.25
Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria. Clin Infect Dis (1994) 1.24
Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam. Aliment Pharmacol Ther (1998) 1.24
Relatedness of human and animal Clostridium difficile PCR ribotype 078 isolates determined on the basis of multilocus variable-number tandem-repeat analysis and tetracycline resistance. J Clin Microbiol (2010) 1.23
First isolation of Clostridium difficile 027 in Japan. Euro Surveill (2007) 1.23
Molecular epidemiology of endemic Clostridium difficile infection. Epidemiol Infect (2001) 1.21
Struggling with recurrent Clostridium difficile infections: is donor faeces the solution? Euro Surveill (2009) 1.20
Evidence to support the existence of subgroups within the UK epidemic Clostridium difficile strain (PCR ribotype 1). J Hosp Infect (2003) 1.19
Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. Euro Surveill (2009) 1.18
[Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces]. Ned Tijdschr Geneeskd (2008) 1.18
Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis (1995) 1.16
Rapid diagnosis of Legionnaires' disease using an immunochromatographic assay for Legionella pneumophila serogroup 1 antigen in urine during an outbreak in the Netherlands. J Clin Microbiol (2000) 1.16
Importance of medium and atmosphere type to both slime production and adherence by coagulase-negative staphylococci. J Hosp Infect (1992) 1.15
Laboratory diagnosis of Clostridium perfringens antibiotic-associated diarrhoea. J Med Microbiol (2002) 1.15
[Epidemiology of Clostridium difficile PCR ribotype 027 in the Netherlands 2005-present and the emergence of other subtypes]. Ned Tijdschr Geneeskd (2008) 1.14
Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection. Eur J Clin Microbiol Infect Dis (2012) 1.12
Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors. Clin Microbiol Infect (2009) 1.12
Fatal mucormycosis presenting as an appendiceal mass with metastatic spread to the liver during chemotherapy-induced granulocytopenia. Scand J Infect Dis (1990) 1.10
Antibiotics and Clostridium difficile. Microbes Infect (1999) 1.10
Binding of mannan-binding protein to various bacterial pathogens of meningitis. Clin Exp Immunol (1994) 1.09
Multiple organ dysfunction syndrome induced by whole-body hyperthermia and polychemotherapy in a patient with disseminated leiomyosarcoma of the uterus. Intensive Care Med (1999) 1.09
Inaccuracy of routine susceptibility tests for detection of erythromycin resistance of Campylobacter jejuni and Campylobacter coli. Clin Microbiol Infect (2010) 1.09
Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea. Clin Microbiol Infect (2012) 1.09
Lymphadenitis in children is caused by Mycobacterium avium hominissuis and not related to 'bird tuberculosis'. Eur J Clin Microbiol Infect Dis (2008) 1.08
Clostridium difficile in Dutch animals: their presence, characteristics and similarities with human isolates. Clin Microbiol Infect (2011) 1.08
Relapse of Legionella longbeachae infection in an immunocompromised patient. Neth J Med (1996) 1.08
Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage--two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea. Neth J Med (2008) 1.08
Vancomycin-resistant enterococci. Lancet (1993) 1.07
Dysfunctional properdin in a Dutch family with meningococcal disease. N Engl J Med (1988) 1.06
Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol (1998) 1.05
Heterozygous and homozygous factor H deficiency states in a Dutch family. Clin Exp Immunol (1996) 1.05
Polymorphism of IgG Fc receptors in meningococcal disease. Ann Intern Med (1993) 1.04
Acquisition of Clostridium difficile by piglets. Vet Microbiol (2010) 1.03
Influence of carbon dioxide on the surface characteristics and adherence potential of coagulase-negative staphylococci. J Clin Microbiol (1990) 1.03
Clarithromycin and risk of Clostridium difficile-associated diarrhoea. J Antimicrob Chemother (2001) 1.03
Comparison of real-time PCR techniques to cytotoxigenic culture methods for diagnosing Clostridium difficile infection. J Clin Microbiol (2010) 1.03
Evidence for antibiotic induced Clostridium perfringens diarrhoea. J Clin Pathol (2001) 1.01
Current application and future perspectives of molecular typing methods to study Clostridium difficile infections. Euro Surveill (2013) 1.01
Comparison of multilocus variable-number tandem-repeat analysis and whole-genome sequencing for investigation of Clostridium difficile transmission. J Clin Microbiol (2013) 1.01
Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital. Clin Infect Dis (2011) 1.00
Prospective evaluation of environmental contamination by Clostridium difficile in isolation side rooms. J Hosp Infect (2001) 1.00
Pneumonia involving Aspergillus and Rhizopus spp. after a near-drowning incident with subsequent Nocardia cyriacigeorgici and N. farcinica coinfection as a late complication. Eur J Clin Microbiol Infect Dis (2005) 1.00
Review article: antibiotic-induced Clostridium difficile infection. Aliment Pharmacol Ther (1996) 1.00
Assessment of a chemiluminescent universal probe for taxonomical and epidemiological investigations of Aeromonas sp isolates. J Clin Pathol (1994) 0.99
Whole genome sequencing reveals potential spread of Clostridium difficile between humans and farm animals in the Netherlands, 2002 to 2011. Euro Surveill (2014) 0.99